- Title
- Time from completion of chemotherapy to disease progression as a clinically relevant endpoint in women with epithelial ovarian, primary peritoneal, and fallopian tube cancers treated with and without bevacizumab
- Creators
- L. Randall - University of California, Irvine Medical CenterR. Burger - Fox Chase Cancer CenterH. Nguyen - GenentechG. Kong - GenentechM. Bookman - University of ArizonaG. Fleming - University of ChicagoB. Monk - Creighton UniversityR. Mannel - University of OklahomaM. Birrer - Massachusetts General Hospital
- Publication Details
- Gynecologic oncology, Vol.130(1), pp.e120-e120
- Publisher
- Elsevier Inc
- Identifiers
- 991005969160102656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Time from completion of chemotherapy to disease progression as a clinically relevant endpoint in women with epithelial ovarian, primary peritoneal, and fallopian tube cancers treated with and without bevacizumab
Gynecologic oncology, Vol.130(1), pp.e120-e120
07/2013
Metrics
4 Record Views